sodium bisulfide has been researched along with Liver Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, W; Li, J; Li, Q; Tu, F; Wang, J | 1 |
| Li, JX; Li, Q; Tu, FP; Wang, J | 1 |
2 other study(ies) available for sodium bisulfide and Liver Diseases
| Article | Year |
|---|---|
Hydrogen sulfide protects against cognitive impairment induced by hepatic ischemia and reperfusion via attenuating neuroinflammation.
Topics: Animals; Calcium-Binding Proteins; Cognition Disorders; Cytokines; Disease Models, Animal; Hippocampus; Injections, Intraperitoneal; Ischemia; Liver Diseases; Male; Microfilament Proteins; Neurologic Examination; Neuroprotective Agents; Rats, Sprague-Dawley; Reperfusion Injury; Sulfides; Treatment Outcome | 2016 |
Effects of hydrogen sulfide on cognitive dysfunction and NR2B in rats.
Topics: Animals; Biomarkers; Blotting, Western; Cognitive Dysfunction; Drug Administration Schedule; Hippocampus; Hydrogen Sulfide; Injections, Intraperitoneal; Liver Diseases; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; Sulfides; Treatment Outcome | 2016 |